Quimioprevención del cáncer - IntraMed - Artículos
IntraMed
 
INGRESAR
¿Olvidó su contraseña?
Regístrese ahora
Contáctenos
Centro de ayuda
  Inicio
 Artículos
 Puntos de vista
 Entrevistas
 Noticias médicas
 Campus Virtual
 Journal
 Biblioteca Virtual
 Investigaciones
 Foros
 Eventos
 Vademécum
 Arte & Cultura
 Tecnología
 » Enlaces
 » Encuestas
 » Clasificados
 » Pág. Profesionales
 » Tarjetas Virtuales
Artículos
          
  
27 OCT 04 | Segunda parte
Quimioprevención del cáncer
Esta segunda parte trata sobre la quimioprevención de diferentes cánceres: mama, colorrectal, cabeza y cuello, pulmón, vejiga, próstata, piel y cérvix.

Dres. Tsao AS, Kim ES, Hong WK.
Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA
CA Cancer J Clin. 2004 May-Jun;54(3):150-80.
 
ÍNDICE 
Desarrollo
Cáncer colorrectal y de cabeza y cuello
Cáncer de pulmón y vejiga
Cáncer de próstata, piel y cervical
Bibliografía
Bibliografía
61. Brennan JA, Mao L, Hruban RH, et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 1995; 332: 429-435.

62. Sidransky D, Tokino T, Hamilton SR, et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 1992; 256: 102-105.

63.  Sidransky D, Mikkelsen T, Schwechheimer K, et al. Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 1992; 355: 846-847.

64. Mao L, Hruban RH, Boyle JO, et al. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res 1994; 54: 1634-1637.

65. Zhang Z, Nakamura M, Taniguchi E, et al. Late occurrence of K-ras gene mutations in the pathogenesis of squamous cell carcinoma of the lung: analysis in sputum. Anal Quant Cytol Histol 1996; 18: 501-502.

66. Rusch V, Klimstra D, Venkatraman E, et al. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression. Clin Cancer Res 1997; 3: 515-522.

67. Rusch V, Mendelsohn J, Dmitrovsky E. The epidermal growth factor receptor and its ligands as therapeutic targets in human tumors. Cytokine Growth Factor Rev 1996; 7: 133-141.

68. Lippman SM, Lee JS, Lotan R, et al. Biomarkers as intermediate end points in chemoprevention trials. J Natl Cancer Inst 1990; 82: 555-560.

69. Simpson JF, Page DL. Pathology of preinvasive and excellent prognosis breast cancer. Curr Opin Oncol 2001; 13: 426-430.

70. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525-532.

71. Toyota M, Shen L, Ohe-Toyota M, et al. Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors. Cancer Res 2000; 60: 4044-4048.

72. Lee JJ, Hong WK, Hittelman WN, et al. Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res 2000; 6: 1702-1710.

73. van Houten VM, Tabor MP, van den Brekel MW, et al. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer. J Pathol 2002; 198: 476-486.

74. Takahashi T, Nau MM, Chiba I, et al. p53: a frequent target for genetic abnormalities in lung cancer. Science. 1989; 246: 491-494.

75. Mitsudomi T, Steinberg SM, Nau MM, et al. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 1992; 7: 171-180.

76. Sugio K, Kishimoto Y, Virmani AK, et al. K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas. Cancer Res 1994; 54: 5811-5815.

77. Hirano T, Franzen B, Kato H, et al. Genesis of squamous cell lung carcinoma. Sequential changes of proliferation, DNA ploidy, and p53 expression. Am J Pathol 1994; 144: 296-302.

78. Leffell DJ. The scientific basis of skin cancer. J Am Acad Dermatol 2000; 42: 18-22.
79. Ziegler A, Jonason AS, Leffell DJ, et al. Sunburn and p53 in the onset of skin cancer. Nature 1994; 372: 773-76.

80. Buckman SY, Gresham A, Hale P, et al. COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis 1998; 19: 723-729.

81. Peus D, Vasa RA, Meves A, et al. H2O2 is an important mediator of UVB-induced EGF-receptor phosphorylation in cultured keratinocytes. J Invest Dermatol 1998; 110: 966-971.

82. Morkve O, Halvorsen OJ, Stangeland L, et al. Quantitation of biological tumor markers (p53, c-myc, Ki-67 and DNA ploidy) by multiparameter flow cytometry in non-small-cell lung cancer. Int J Cancer 1992; 52: 851-855.

83. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med 1993; 328: 184-194.

84. Acs G, Lawton TJ, Rebbeck TR, et al. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol. 2001; 115: 85-98.

85. Soria JC, Moon C, Wang L, et al. Effects of N-(4-hydroxyphenyl)retinamide on hTERT expression in the bronchial epithelium of cigarette smokers. J Natl Cancer Inst 2001; 93: 1257-1263.

86. Lotan R, Xu XC, Lippman SM, et al. Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin. N Engl J Med 1995; 332: 1405-1410.

87. Califano J, van der Riet P, Westra W, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996; 56: 2488-2492.

88. Mao L, Lee JS, Fan YH, et al. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med 1996; 2: 682-685.

89. Hittelman WN, Voravud N, Shin DM, et al. Early genetic changes during upper aerodigestive tract tumorigenesis. J Cell Biochem Suppl 1993; 17F: 233-236.

90. Papadimitrakopoulou V, Izzo J, Lippman SM, et al. Frequent inactivation of p16INK4a in oral premalignant lesions. Oncogene 1997; 14: 1799-1803.

91. Mao L, Fan YH, Lotan R, Hong WK. Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. Cancer Res 1996; 56: 5128-5131.

92. Tsao AS, McDonnell T, Lam S, et al. Increased phospho-AKT (Ser(473)) expression in bronchial dysplasia: implications for lung cancer prevention studies. Cancer Epidemiol Biomarkers Prev 2003; 12: 660-664.

93. Hirsch FR, Franklin WA, Gazdar AF, Bunn PA Jr. Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. Clin Cancer Res 2001; 7: 5-22.

94. Wistuba II, Lam S, Behrens C, et al. Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst 1997; 89: 1366-1373.

95. Sozzi G, Veronese ML, Negrini M, et al. The FHIT gene 3p14.2 is abnormal in lung cancer. Cell 1996; 85: 17-26.

96. Hung J, Kishimoto Y, Sugio K, et al. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 1995; 273: 558-563.

97. Tockman MS, Mulshine JL, Piantadosi S, et al. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. Clin Cancer Res 3: 2237-2246.

98. Pezzella F, Turley H, Kuzu I, et al. bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med 1993; 329: 690-694.

99. Walker C, Robertson L, Myskow M, Dixon G. Expression of the BCL-2 protein in normal and dysplastic bronchial epithelium and in lung carcinomas. Br J Cancer 1995; 72: 164-169.

100. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996; 87: 159-170.
 
« Página anterior
          
  


 Comentarios de los lectores
 

Usted debe estar registrado para expresar su opinión.
Si ya es usuario de IntraMed o desea registrase como nuevo
usuario, ingrese aquí

 



Eventos

» XIV Congreso SADI 2014 - Rosario, Argentina
» VIII Congreso Argentino de Zoonosis - La Plata, Argentina
» Abordaje Integral del Adolescente - A distancia
» V Congreso Interamericano de Medicina de Emergencias - Buenos Aires, Argentina
» 15° Congreso Internacional de Medicina Interna del Hospital - Buenos Aires, Argentina
» Máster en Gestión de Centros y Servicios de Salud - A distancia
» Máster en Medicina Antienvejecimiento y Longevidad - A distancia
» VII Simposio Internacional de HTA-Rosario - Rosario, Argentina
» X Simposio Internacional de CIDEMO 2014 - Mar del Plata, Argentina
» Residencia de Emergencias - Pilar, Argentina

Foros

» Narativa y Medicina
» Kinesiología y Fisioterapia
» Prevención Cardiovascular
» Medicina Legal
» Médicos Residentes
» Enfermería
» Bioética
» Neurología
» Jerga Médica
» Estudiantes
» Salud Mental
» Tocoginecología
» Clínica Médica
» Cirugía
» Pediatría
» Cardiología
» Búsqueda Bibliográfica

Más comentados
1. 40 cosas que los médicos no deberíamos olvidar
2. Curso Virtual de Electrocardiografía Clínica IntraMed
3. Diagnóstico diferencial del ojo rojo
4. Necesidad del razonamiento clínico en la era de la medicina basada en la evidencia
5. Semana Mundial de la Inmunización
Más visitados
1. Tratamiento del shock séptico
2. Diagnóstico diferencial del ojo rojo
3. Puesta al día: Lumbalgia
4. ¿Cómo responder a las campañas antivacunas?
5. Puesta al día: Mal de Chagas


Quiénes somos | Contáctenos | Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2014